COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial

Marquita Camilleri; Jonathan Sive; William Wilson; Gavin Pang; Richard Jenner; Elizabeth Phillips; Rakesh Popat; Karthik Ramasamy; Ceri Bygrave; Tushhar Dadaga; Matthew Streetly; James Cavenagh; Mike Chapman; Sally Barrington; Lucy Pike; Roger Owen; Laura Clifton-Hadley; Kwee Yong

doi:10.1111/bjh.17168

COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial

Marquita Camilleri^*, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, Rakesh Popat, Karthik Ramasamy, Ceri Bygrave, Tushhar Dadaga, Matthew Streetly, James Cavenagh, Mike Chapman, Sally Barrington, Lucy Pike, Roger Owen, Laura Clifton-Hadley, Kwee Yong

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	e14-e16
Journal	British Journal of Haematology
Volume	192
Issue number	1
DOIs	https://doi.org/10.1111/bjh.17168
Publication status	Published - Jan 2021

Keywords

clinical trials
COVID-19
myeloma

Access to Document

10.1111/bjh.17168

Cite this

Camilleri, M., Sive, J., Wilson, W., Pang, G., Jenner, R., Phillips, E., Popat, R., Ramasamy, K., Bygrave, C., Dadaga, T., Streetly, M., Cavenagh, J., Chapman, M., Barrington, S., Pike, L., Owen, R., Clifton-Hadley, L., & Yong, K. (2021). COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial. British Journal of Haematology, 192(1), e14-e16. https://doi.org/10.1111/bjh.17168

@article{1fd1ce9817a54f48ae1985f311b7d30d,

title = "COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial",

keywords = "clinical trials, COVID-19, myeloma",

author = "Marquita Camilleri and Jonathan Sive and William Wilson and Gavin Pang and Richard Jenner and Elizabeth Phillips and Rakesh Popat and Karthik Ramasamy and Ceri Bygrave and Tushhar Dadaga and Matthew Streetly and James Cavenagh and Mike Chapman and Sally Barrington and Lucy Pike and Roger Owen and Laura Clifton-Hadley and Kwee Yong",

note = "Funding Information: CARDAMON is coordinated by the CRUK & UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Funding Information: Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Funding Information: CARDAMON is coordinated by the CRUK & UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Professor Barrington also acknowledges support from the NIHR (RP-2-16-07-001). King?s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King?s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Funding Information: Professor Barrington also acknowledges support from the NIHR (RP‐2‐16‐07‐001). King{\textquoteright}s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King{\textquoteright}s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jan,

doi = "10.1111/bjh.17168",

language = "English",

volume = "192",

pages = "e14--e16",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "1",

}

Camilleri, M, Sive, J, Wilson, W, Pang, G, Jenner, R, Phillips, E, Popat, R, Ramasamy, K, Bygrave, C, Dadaga, T, Streetly, M, Cavenagh, J, Chapman, M, Barrington, S , Pike, L, Owen, R, Clifton-Hadley, L & Yong, K 2021, 'COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial', British Journal of Haematology, vol. 192, no. 1, pp. e14-e16. https://doi.org/10.1111/bjh.17168

TY - JOUR

T1 - COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial

AU - Camilleri, Marquita

AU - Sive, Jonathan

AU - Wilson, William

AU - Pang, Gavin

AU - Jenner, Richard

AU - Phillips, Elizabeth

AU - Popat, Rakesh

AU - Ramasamy, Karthik

AU - Bygrave, Ceri

AU - Dadaga, Tushhar

AU - Streetly, Matthew

AU - Cavenagh, James

AU - Chapman, Mike

AU - Barrington, Sally

AU - Pike, Lucy

AU - Owen, Roger

AU - Clifton-Hadley, Laura

AU - Yong, Kwee

N1 - Funding Information: CARDAMON is coordinated by the CRUK & UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Funding Information: Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Funding Information: CARDAMON is coordinated by the CRUK & UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Professor Barrington also acknowledges support from the NIHR (RP-2-16-07-001). King?s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King?s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Funding Information: Professor Barrington also acknowledges support from the NIHR (RP‐2‐16‐07‐001). King’s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King’s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/1

Y1 - 2021/1

KW - clinical trials

KW - COVID-19

KW - myeloma

UR - http://www.scopus.com/inward/record.url?scp=85096711177&partnerID=8YFLogxK

U2 - 10.1111/bjh.17168

DO - 10.1111/bjh.17168

M3 - Letter

C2 - 33222153

AN - SCOPUS:85096711177

SN - 0007-1048

VL - 192

SP - e14-e16

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 1

ER -

COVID-19 and myeloma clinical research – experience from the CARDAMON clinical trial

Keywords

Access to Document

Other files and links

Cite this